NCT02413736 2025-03-12Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GISTHelsinki University Central HospitalPhase 3 Active not recruiting255 enrolled
NCT00116935 2011-12-30Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)Scandinavian Sarcoma GroupPhase 3 Completed400 enrolled